Search Results - "Spacírova, Zuzana"

Response to the letter to the editor by Olry de Labry Lima, Antonio, Fénix-Caballero, Silvia, Spacírova, Zuzana, Del Rey, Emilio Jesús Alegre

Get full text

The patient, diagnostic, and treatment intervals in adult patients with cancer from high- and lower-income countries: A systematic review and meta-analysis by Petrova, Dafina, Špacírová, Zuzana, Fernández-Martínez, Nicolás Francisco, Ching-López, Ana, Garrido, Dunia, Rodríguez-Barranco, Miguel, Pollán, Marina, Redondo-Sánchez, Daniel, Espina, Carolina, Higueras-Callejón, Camila, Sánchez, Maria José

“…Longer time intervals to diagnosis and treatment are associated with worse survival for various types of cancer. The patient, diagnostic, and treatment…”
Get full text

A general framework for classifying costing methods for economic evaluation of health care by Špacírová, Zuzana, Epstein, David, García-Mochón, Leticia, Rovira, Joan, de Labry Lima, Antonio Olry, Espín, Jaime

“…According to the most traditional economic evaluation manuals, all "relevant" costs should be included in the economic analysis, taking into account factors…”
Get full text

Development of the European Healthcare and Social Cost Database (EU HCSCD) for use in economic evaluation of healthcare programs by Espín, Jaime, Špacírová, Zuzana, Rovira, Joan, Epstein, David, Olry de Labry Lima, Antonio, García-Mochón, Leticia

“…Costs are one of the critical factors for the transferability of the results in health technology assessment and economic evaluation. The objective is to…”
Get full text

Description of day case costs and tariffs of cataract surgery from a sample of nine European countries by Olry de Labry Lima, Antonio, Špacírová, Zuzana, Espín, Jaime

“…The lack of transparency in the methodology of unit cost estimation and the usage of confidential or undisclosed information prevents cost comparisons and…”
Get full text

Are costs derived from diagnosis-related groups suitable for use in economic evaluations? A comparison across nine European countries in the European Healthcare and Social Cost Database by Špacírová, Zuzana, Epstein, David, Espín, Jaime

“…Background Economic evaluation of health technologies requires healthcare resources, procedures and services to be valued at their opportunity cost. In…”
Get full text

Costing methodologies in European economic evaluation guidelines: commonalities and divergences by García-Mochón, Leticia, Špacírová, Zuzana, Espín, Jaime

“…From both the methodological point of view and standardization of methodology, little attention has been paid to the estimation of direct costs in evaluation…”
Get full text

Duration of the patient interval in breast cancer and factors associated with longer delays in low‐and middle‐income countries: A systematic review with meta‐analysis by Petrova, Dafina, Garrido, Dunia, Špacírová, Zuzana, Fernández‐Martínez, Nicolás Francisco, Ivanova, Ganka, Rodríguez‐Barranco, Miguel, Pollán, Marina, Barrios‐Rodríguez, Rocío, Sánchez, Maria José

“…Objective Breast cancer survival is lower in low‐ and middle‐income countries (LMICs) partially due to many women being diagnosed with late‐stage disease. The…”
Get full text

Cost-utility of talazoparib monotherapy treatment for locally advanced or metastatic breast cancer in Spain by Olry de Labry Lima, Antonio, Špacírová, Zuzana, Fénix-Caballero, Silvia, Hoces, Antonio Matas, Vegas, Adrián Sánchez, Aranzana, Manuel Cárdenas, Sierra-Sánchez, Jesús F., Díaz, María del Carmen Martínez, Alegre del Rey, Emilio Jesús

“…Breast cancer is one of the most frequent malignancies. The aim of the article is to analyse the cost-utility ratio and budgetary impact of talazoparib…”
Get full text

Economic evaluation of adjuvant therapy with osimertinib in patients with early-stage non–small cell lung cancer and mutated EGFR by Vila Pérez, Alejandro, Alegre-del Rey, Emilio J., Fénix-Caballero, Silvia, Špacírová, Zuzana, Rosado Varela, Petra, Olry de Labry Lima, Antonio

“…Purpose The ADAURA trial demonstrated the superiority of osimertinib over a placebo with regard to disease-free survival, showing it to be indicated as an…”
Get full text

Correction to: A general framework for classifying costing methods for economic evaluation of health care by Špacírová, Zuzana, Epstein, David, García-Mochón, Leticia, Rovira, Joan, Olry de Labry Lima, Antonio, Espín, Jaime

“…A correction to this paper has been published: https://doi.org/10.1007/s10198-021-01313-0…”
Get full text

The duration of intervals on the oral cancer care pathway and implications for survival: a systematic review and meta-analysis by Fernández-Martínez, Nicolás Francisco, Petrova, Dafina, Špacírová, Zuzana, Barrios-Rodríguez, Rocío, Pérez-Sayáns, Mario, Martín-delosReyes, Luis Miguel, Pérez-Gómez, Beatriz, Rodríguez-Barranco, Miguel, Sánchez, María José

“…Introduction Previous studies measuring intervals on the oral cancer care pathway have been heterogenous, showing mixed results with regard to patient…”
Get full text

Cost-effectiveness of a primary care-based exercise intervention in perimenopausal women. The FLAMENCO Project by Špacírová, Zuzana, Epstein, David, García-Mochón, Leticia, Aparicio, Virginia A., Borges-Cosic, Milkana, López del Amo, M. Puerto, Martín-Martín, José J.

“…Adequate physical activity levels and a healthy lifestyle may prevent all kinds of non-communicable diseases, promote well-being and reduce health-care costs…”
Get full text

The cost-effectiveness of a uniform versus age-based threshold for one-off screening for prevention of cardiovascular disease by Špacírová, Zuzana, Kaptoge, Stephen, García-Mochón, Leticia, Rodríguez Barranco, Miguel, Sánchez Pérez, María José, Bondonno, Nicola P., Tjønneland, Anne, Weiderpass, Elisabete, Grioni, Sara, Espín, Jaime, Sacerdote, Carlotta, Schiborn, Catarina, Masala, Giovanna, Colorado-Yohar, Sandra M., Kim, Lois, Moons, Karel G. M., Engström, Gunnar, Schulze, Matthias B., Bresson, Léa, Moreno-Iribas, Concepción, Epstein, David

“…The objective of this article was to assess the cost-effectiveness of screening strategies for cardiovascular diseases (CVD). A decision analytic model was…”
Get full text

Cost-effectiveness of an exercise intervention program in perimenopausal women: the Fitness League Against MENopause COst (FLAMENCO) randomized controlled trial by Carbonell-Baeza, Ana, Soriano-Maldonado, Alberto, Gallo, Francisco Javier, López del Amo, María Puerto, Ruiz-Cabello, Pilar, Andrade, Ana, Borges-Cosic, Milkana, Peces-Rama, Antonio Rubén, Spacírová, Zuzana, Álvarez-Gallardo, Inmaculada C, García-Mochón, Leticia, Segura-Jiménez, Víctor, Estévez-López, Fernando, Camiletti-Moirón, Daniel, Martín-Martín, Jose Jesús, Aranda, Pilar, Delgado-Fernández, Manuel, Aparicio, Virginia A

“…The high prevalence of women that do not reach the recommended level of physical activity is worrisome. A sedentary lifestyle has negative consequences on…”
Get full text

The patient, diagnostic, and treatment intervals in adult patients with cancer from high- and lower-income countries: A systematic review and meta-analysis by Dafina Petrova, Zuzana Špacírová, Nicolás Francisco Fernández-Martínez, Ana Ching-López, Dunia Garrido, Miguel Rodríguez-Barranco, Marina Pollán, Daniel Redondo-Sánchez, Carolina Espina, Camila Higueras-Callejón, Maria José Sánchez

“…Background Longer time intervals to diagnosis and treatment are associated with worse survival for various types of cancer. The patient, diagnostic, and…”
Get full text